FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $723,000 | -70.5% | 201,478 | -52.9% | 0.09% | -62.8% |
| Q3 2018 | $2,450,000 | -42.8% | 427,500 | -50.0% | 0.25% | -55.3% |
| Q2 2018 | $4,284,000 | -2.3% | 855,000 | 0.0% | 0.55% | -11.1% |
| Q1 2018 | $4,386,000 | -14.7% | 855,000 | 0.0% | 0.62% | -43.6% |
| Q4 2017 | $5,139,000 | +8.3% | 855,000 | 0.0% | 1.10% | +14.8% |
| Q3 2017 | $4,745,000 | +19.6% | 855,000 | 0.0% | 0.96% | -4.0% |
| Q2 2017 | $3,967,000 | -6.3% | 855,000 | 0.0% | 1.00% | -19.8% |
| Q1 2017 | $4,232,000 | -55.4% | 855,000 | 0.0% | 1.24% | -60.2% |
| Q4 2016 | $9,491,000 | +19.9% | 855,000 | 0.0% | 3.13% | +26.8% |
| Q3 2016 | $7,917,000 | – | 855,000 | – | 2.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,667,377 | $15,440,000 | 9.38% |
| GREAT POINT PARTNERS LLC | 2,769,425 | $25,645,000 | 6.54% |
| Opaleye Management Inc. | 630,000 | $5,834,000 | 3.05% |
| Vivo Capital, LLC | 855,000 | $7,917,000 | 2.47% |
| DAFNA Capital Management LLC | 278,067 | $2,575,000 | 1.79% |
| RA Capital Management | 1,820,138 | $16,854,000 | 1.74% |
| SENZAR ASSET MANAGEMENT, LLC | 523,397 | $4,846,656,000 | 1.25% |
| Perceptive Advisors | 1,373,284 | $12,717,000 | 0.82% |
| Monashee Investment Management LLC | 225,000 | $2,084,000 | 0.73% |
| NEXTHERA CAPITAL LP | 125,000 | $1,158,000 | 0.71% |